- Home
- >Arpeggio Bio
Arpeggio Bio
Arpeggio Bio develops drugs targeting transcription factors using AI…
Company
Website
http://www.arpeggiobio.comLocations
Boulder, CO, USA
Team Size
20
Industries
Healthcare, Drug Discovery and Delivery
About
Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted "undruggable" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant melanoma. With partnerships with J&J and FORMA, we've validated our platform in rare disease and inflammation with a significant Phase I success.
Founders
A list of all active founders
Sign-In
An account is required to download data from YCRM.
Almost There!
YCRM requires a one-time $30 payment to get access.
What You Get
- Unlimited downloads for 30 days
- 5000+ YC founders' email, LinkedIn, and Twitter
- Access to the latest YC batches
- Access to all CRM data enhancements
Payment Successful
Congrats! You now have unlimited access to the YCRM database for 30 days. If you have any questions or run into issues, please don't hesitate to reach out. We are here to help.
| Name | Title | |||
|---|---|---|---|---|
Joey Azofeifa | Founder | Sign-InAn account is required to download data from YCRM. Almost There!YCRM requires a one-time $30 payment to get access. What You Get
Payment SuccessfulCongrats! You now have unlimited access to the YCRM database for 30 days. If you have any questions or run into issues, please don't hesitate to reach out. We are here to help. |